Most Recent
Celebrity surgeon loses defamation suit against Nine
A court has ruled that media reports accusing well-known orthopaedic surgeon Dr Munjed Al Muderis of unethical and profit-driven promotion of an experimental procedure were substantially true, tossing his defamation suit against Fairfax and its owner Nine.  
Ex-iSignthis director to appeal $1M fine, disqualification
Former director of fintech iSignthis, John Karantzis, plans to appeal a ruling that slapped him with a $1 million penalty and disqualification orders for allegedly providing misleading information to shareholders. 
Novartis’ last ditch bid to block Entresto generic fails
The High Court has rejected Novartis' plea that it overturn a ruling that found an extension of the term of the patent for its heart drug Entresto was invalidly granted.
High Court to hear developer Mayfield’s appeal in case against NSW Ports
Mayfield Development has been granted the High Court's leave to make its argument that derivative Crown immunity does not apply to NSW Ports, in a seven-year-old competition case. 
Sunshine Loans’ case over judge’s recusal to be heard by High Court
The High Court will hear an appeal by Sunshine Loans, which centres on a judge's recusal in the corporate regulator's case over unauthorised fees.
Optus faces privacy regulator’s case over data breach
The privacy regulator has brought a case against Optus over a 2022 data breach that affected up to 10 million people, as the telco faces a class action and related proceedings by the media regulator.
iSignthis, director hit with $11M in penalties in ASIC case
A judge has handed iSignthis and its director $11 million in penalties for failing to give adequate disclosures and giving misleading information to the ASX, saying reliance on legal advice was no reason to reduce the fine.
Construction PRO
Ex-EY partner in ATO trial says he gave objective advice over developments
A former EY partner accused by the ATO of promoting a tax avoidance scheme over property developments has told a trial judge the commissioner has "overreached".
Trial over Cosette’s termination of $672M Mayne Pharma merger delayed
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Firms that team up to avoid class action beauty parade could breach competition law: judge
A judge that granted carriage of a Google ad tech class action to Maurice Blackburn and Phi Finney McDonald has reiterated concerns that such cooperative arrangements between firms could breach competition law.